Page last updated: 2024-11-12

kp-496

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

KP-496: a dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11578433
SCHEMBL ID1222956
MeSH IDM0520657

Synonyms (15)

Synonym
L018726
SCHEMBL1222956
kp-496
kp496
CS-7445
HY-U00253
qqb95vud4b ,
benzoic acid, 2-(((4-(((4-chlorophenyl)sulfonyl)amino)butyl)((3-((4-(1-methylethyl)-2-thiazolyl)methoxy)phenyl)methyl)amino)sulfonyl)-
kp-496ns
s-36496
2-(4-((4-chlorophenyl)sulfonylamino)butyl-((3-((4-isopropylthiazol-2-yl)methoxy)phenyl)methyl)sulfamoyl)benzoic acid
unii-qqb95vud4b
217799-03-6
2-[4-[(4-chlorophenyl)sulfonylamino]butyl-[[3-[(4-propan-2-yl-1,3-thiazol-2-yl)methoxy]phenyl]methyl]sulfamoyl]benzoic acid
AKOS040733535
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]